IOL Chemicals And Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue showed a healthy recovery in the latest quarter, increasing from ₹503.92 crore to ₹525.75 crore.
Net profit margin improved slightly to 3.26% in the latest quarter, indicating better cost management.
Operating profit margins remained relatively stable, suggesting operational efficiency amidst fluctuating revenues.

NEGATIVES

Net profit decreased significantly to ₹19.15 crore in the latest quarter from ₹29.97 crore previously, reflecting profitability challenges.
Revenue has generally declined over the last four quarters, indicating potential market share loss or demand issues.
Expenses have remained high relative to revenue, suggesting pressure on profit margins and operational sustainability.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	545.30	520.39	503.92	502.38	525.75	523.30	527.78	551.69
Expenses	501.23	496.68	474.24	470.24	506.24	499.57	487.61	513.55
Operating Profit	44.07	23.71	29.68	32.14	19.51	23.73	40.17	38.14
Other Income	7.11	8.38	7.52	7.38	6.43	4.07	4.53	7.37
Interest	4.44	4.30	3.41	2.15	4.12	4.46	4.03	4.23
Depreciation	15.69	16.34	16.43	16.82	17.94	18.68	18.55	19.77
Profit Before Tax	51.18	32.09	37.20	39.52	25.94	27.80	44.70	45.51
Tax	13.31	9.01	9.58	9.55	6.79	7.27	13.28	11.58
Net Profit	37.87	23.08	27.62	29.97	19.15	20.53	31.42	33.93
Eps in Rs	6.45	3.93	4.71	5.11	3.26	3.50	1.07	1.16